1. Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid. Issue 5 (19th March 2013) Authors: Idrees, Atif S. M.; Sugie, Tomoharu; Inoue, Chiyomi; Murata‐Hirai, Kaoru; Okamura, Haruki; Morita, Craig T.; Minato, Nagahiro; Toi, Masakazu; Tanaka, Yoshimasa Journal: Cancer science Issue: Volume 104:Issue 5(2013:May) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cover Picture: Targeting Cancer Cells with a Bisphosphonate Prodrug (ChemMedChem 24/2016). (16th December 2016) Authors: Matsumoto, Kenji; Hayashi, Kosuke; Murata‐Hirai, Kaoru; Iwasaki, Masashi; Okamura, Haruki; Minato, Nagahiro; Morita, Craig T.; Tanaka, Yoshimasa Journal: ChemMedChem Issue: Volume 11:Number 24(2016) Page Start: 2639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation. Issue 1 (21st February 2017) Authors: Nada, Mohanad H.; Wang, Hong; Workalemahu, Grefachew; Tanaka, Yoshimasa; Morita, Craig T. Journal: Journal for immunotherapy of cancer Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug. Issue 3 (4th February 2018) Authors: Tanaka, Yoshimasa; Murata‐Hirai, Kaoru; Iwasaki, Masashi; Matsumoto, Kenji; Hayashi, Kosuke; Kumagai, Asuka; Nada, Mohanad H.; Wang, Hong; Kobayashi, Hirohito; Kamitakahara, Hiroshi; Okamura, Haruki; Sugie, Tomoharu; Minato, Nagahiro; Toi, Masakazu; Morita, Craig T. Journal: Cancer science Issue: Volume 109:Issue 3(2018) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Front Cover: Synthesis and Immunomodulatory Activity of Fluorine‐Containing Bisphosphonates (ChemMedChem 4/2019). (19th February 2019) Authors: Mizuta, Satoshi; Tagod, Mohammed S. O.; Iwasaki, Masashi; Nakamura, Yoichi; Senju, Hiroaki; Mukae, Hiroshi; Morita, Craig T.; Tanaka, Yoshimasa Journal: ChemMedChem Issue: Volume 14:Number 4(2019) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Live Cell Labeling with Terpyridine Derivative Proligands to Measure Cytotoxicity Mediated by Immune Cells. (4th December 2017) Authors: Sakai, Yuki; Mizuta, Satoshi; Kumagai, Asuka; Tagod, Mohammed S. O.; Senju, Hiroaki; Nakamura, Tatsufumi; Morita, Craig T.; Tanaka, Yoshimasa Journal: ChemMedChem Issue: Volume 12:Number 23(2017) Page Start: 2006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer. (1st January 2021) Authors: Nada, Mohanad H.; Wang, Hong; Hussein, Auter J.; Tanaka, Yoshimasa; Morita, Craig T. Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Synthesis and Immunomodulatory Activity of Fluorine‐Containing Bisphosphonates. (25th January 2019) Authors: Mizuta, Satoshi; Tagod, Mohammed S. O.; Iwasaki, Masashi; Nakamura, Yoichi; Senju, Hiroaki; Mukae, Hiroshi; Morita, Craig T.; Tanaka, Yoshimasa Journal: ChemMedChem Issue: Volume 14:Number 4(2019) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeting Cancer Cells with a Bisphosphonate Prodrug. (27th October 2016) Authors: Matsumoto, Kenji; Hayashi, Kosuke; Murata‐Hirai, Kaoru; Iwasaki, Masashi; Okamura, Haruki; Minato, Nagahiro; Morita, Craig T.; Tanaka, Yoshimasa Journal: ChemMedChem Issue: Volume 11:Number 24(2016) Page Start: 2656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗